Dr. Turka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
210 White Building
Philadelphia, PA 19104Phone+1 215-662-2638Fax+1 215-349-5703
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1985 - 1988
Yale-New Haven Medical CenterResidency, Internal Medicine, 1983 - 1985- Yale-New Haven Medical CenterInternship, Internal Medicine, 1982 - 1983
Yale School of MedicineClass of 1982
Certifications & Licensure
PA State Medical License 1994 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Associating Renal Transplantation With the ITN Signature of Tolerance Start of enrollment: 2010 Sep 01
- A Cohort Study of Operationally Tolerant Allograft Recipients Start of enrollment: 2016 Jun 30
Publications & Presentations
PubMed
- 4 citationsHarnessing regulatory T cells to establish immune tolerance.Patrick Ho, Ellen Cahir-McFarland, Jason D Fontenot, Tracey Lodie, Adel Nada
Science Translational Medicine. 2024-03-13 - 5 citationsDonor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial.Eva C Guinan, Laura Contreras-Ruiz, Kerry Crisalli, Charles Rickert, Ivy Rosales
American Journal of Transplantation. 2023-12-01 - 6 citationsEx vivo generation of regulatory T cells from liver transplant recipients using costimulation blockadeKatsuyoshi Shimozawa, Laura Contreras-Ruiz, Sofia Sousa, Ruan Zhang, Urvashi Bhatia
American Journal of Transplantation. 2021-09-15
Journal Articles
- Maintenance of CD4 T Cell Fitness Through Regulation of Foxo1Bruce R Blazar, Laurence A Turka, Nature
Press Mentions
Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology DaysMay 15th, 2020
Biological 'Atlas' Shows Dual Personality for Immune Cells That Cause Type 1 DiabetesMarch 30th, 2020
Rubius Therapeutics Appoints Internationally Recognized Autoimmunity and Translational Immunology Leader Laurence Turka, M.D., as Chief Scientific OfficerJanuary 8th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
